Lawyers Reviewing Invokana Amputation Cases Nationwide
Invokana (canagliflozin) was introduced as part of a new generation of diabetes treatments in March 2013, and quickly grew to become a blockbuster drug. However, after more and more diabetics were switched the drug, concerns quickly emerged about the large number of Invokana amputation problems reported among users, which are not seen at the same rates among users of competing type 2 diabetes medications.
Contact Our Lawyers About a INVOKANA LAWSUIT
As a result of the drug maker’s failure to warn about the potential amputation side effects of Invokana, lawsuits are being pursued for individuals who have required:
- Leg Amputation
- Foot Amputation
- Toe Amputation
- Other Complications from Invokana
In addition to Invokana amputation lawsuits, our law firm previously reviewed claims for users who have suffered diabetic ketoacidosis, kidney failure, heart attacks and other injuries. New cases are no longer accepted for those other injuries.
All amputation cases are handled by our lawyers under a contingency fee agreement, which means that there are never any out-of-pocket costs to hire our law firm, and we receive no attorneys fees or reimbursed expenses unless a recovery or settlement is obtained. Request a free consultation and claim evaluation.
Invokana Amputation Side Effects
Invokana was the first member of a new class of type 2 diabetes drugs, known as sodium-glucose cotransporter-2 (SGLT2) inhibitors. It is also marketed under the brand name Invokamet, which combines the active ingredient with metformin. However, other members of this new class of drugs include Farxiga, Jardiance, Glyxambi, Xigduo and others.
While a number of serious side effects have been linked to this new generation of diabetes treatments since they were introduced, the amputation risks with Invokana and Invokamet appear to be especially high.
Amputation problems became increasingly apparent as doctors and patients submitted adverse event reports, and after interim results from an on-going clinical trial were released, known as CANVAS.
In May 2016, the FDA first issued an Invokana and Invokamet amputation warning, indicating that the agency was reviewing this new safety issue after finding an increase in leg and foot amputations, mostly affecting the toes.
For the first time, information was provided to users and doctors about the potential link between Invokana and amputations, highlighting the importance of monitoring for signs of problems, including:
- Pain in the Feet or Legs
- Tenderness
- Leg or Foot Sores and Ulcers
- Infections involving the Foot or Leg
In May 2017, the FDA announced that new label information about the Invokana amputation side effects would be placed prominently in a “black box”, which is the strongest warning that can be required for a prescription medication.
The agency determined that nearly 6 out of every 1,000 patients that take Invokana or Invokamet may require an amputation, which is double the risk seen among diabetics given a placebo.
Findings of a study published by the New England Journal of Medicine in June 2017 confirm these findings. Although researchers are still investigating the mechanism of the drug that increases amputation risks, doctors were urged to exercise caution and care.
Invokana Amputation Class Action Lawyers
It appears that the drug makers knew or should have known about the increased risk of leg and foot amputations on Invokana, yet placed their desire for profits before consumer safety, by withholding important warnings that may have allowed users and doctors to detect problems before an amputation was necessary.
The lawyers at Saiontz & Kirk, P.A. are reviewing potential Invokana class action lawsuits and individual amputation cases nationwide, providing free consultations and case evaluations.
To determine whether you or a loved one may be eligible for an Invokana settlement or financial recovery, call 1-800-522-0102 or complete our online request form.